Verified July 2026 · Cited to primary sources
Semax: Evidence Grade C. Early / foreign human data only.
A Russian-approved cognitive and neuroprotective peptide with real but non-Western clinical data.
The honest verdict
Semax is not FDA-approved (it is approved in Russia) and remains under FDA review. On July 24, 2026 the PCAC panel voted 8 to 5 (1 abstention) to recommend adding it to the 503A list for cerebral ischemia, migraine and trigeminal neuralgia, but that is advisory and the FDA has not acted. Human evidence is Grade C: real Russian trials, but no Western replication. For the anxiety-focused sister peptide, see our Selank page and our cognitive-peptides hub.
Semax at a glance
- Class
- Synthetic heptapeptide (nootropic)
- Mechanism
- Modulates BDNF and dopaminergic/serotonergic systems. A neuroprotective, cognition-enhancing nootropic peptide.
- Also known as
- ACTH(4-10) analog, Met-Glu-His-Phe-Pro-Gly-Pro
- Research applications
- Cognition and focus / brain fog (Russian clinical use)
- Ischemic stroke recovery and neuroprotection (Russian trials)
- Forms
- intranasal spray/drops
- Legal status
- Under FDA review
- WADA (anti-doping)
- Not prohibited (occasionally monitored, verify)
- Evidence grade
- Grade CEarly / foreign human data only
How we grade evidence
Every grade comes from a fixed A to F rubric: human-trial strength, not hype or affiliate status. Last verified July 6, 2026.
What is Semax?
Compound class: Synthetic heptapeptide (nootropic)
Modulates BDNF and dopaminergic/serotonergic systems. A neuroprotective, cognition-enhancing nootropic peptide.
How strong is the evidence for Semax?
Grade C: approved as a drug in Russia with Russian clinical studies (stroke, cognition), but no rigorous Western RCT replication (rule 4 fired: foreign approval with weak/unreplicated RCTs).
Primary sources (2)
Is Semax legal? (Status July 2026)
Regulatory limbo; the July 2026 PCAC panel has advised, the FDA decision is pending.
July 2026 PCAC vote
On July 24, 2026 the FDA's Pharmacy Compounding Advisory Committee voted to recommend adding Semax to the 503A compounding list (8 to 5, with 1 abstention), overriding the FDA's own scientists. That is an advisory recommendation, not legalization: the FDA still makes the final decision and has not acted, so Semax is not yet legally compoundable. Track the FDA peptide vote →
What is Semax used for?
Semax is marketed for the goals below. See how it ranks against other peptides in each, by evidence, not hype.
What does Semax cost, and how do you access it legally?
Typical cost
UNKNOWN
No verified US clinic price anchor in the research; marked UNKNOWN.
No legal supervised access route right now.
Semax has no compliant US route today while its compounding status is under FDA review. Vials sold "for research use only" are a gray-market fig-leaf, not a legal loophole, so we don't link them. If you pursue Semax, do it with a licensed clinician, and re-check its legal status first.
Telehealth programs do advertise several compounds in this position as prescribable online. We checked those advertised menus against the law in peptide telehealth programs.
Is Semaxsafe? Side effects & risks
Safety data largely limited to Russian post-marketing use; long-term Western safety profile unknown. Not on the WADA list (verify; occasionally monitored).
Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.
Free tool
Peptide reconstitution calculator
Enter the mg in the vial and the ml of bacteriostatic water, and get the concentration plus the units to draw on an insulin syringe. It does the arithmetic on your numbers, and it never suggests a dose. See all four calculators.
FAQ
Semax FAQ
Is Semax approved anywhere?
Yes. Semax is an approved drug in Russia and has Russian clinical studies for stroke recovery and cognition. It is not FDA-approved, and those trials have not been replicated to Western RCT standards, so we grade it C.
Is Semax on the FDA peptide docket?
Yes. Semax is one of the seven peptides the FDA's Pharmacy Compounding Advisory Committee reviews on July 24, 2026.
Is Semax the same as Selank?
No, but they're close cousins: both Russian-developed peptides with real but non-Western human data (both Grade C). Semax is the cognition/neuroprotection peptide; Selank is the anti-anxiety/anti-stress peptide. See our cognitive-peptides hub for the side-by-side.
From our portfolio
Tracking Semax?
Titrate is an iOS app for logging doses, schedules and progress over time, with a reconstitution calculator built in. It tracks, it does not prescribe.
Compare Semax with…
Head-to-head evidence-grade matchups people weigh against Semax.
Keep reading
Selank
A Russian-developed anti-anxiety and nootropic peptide with real but non-Western human trials. In Russian studies it matched a benzodiazepine for anxiety without the sedation or dependence.
Grade DDihexa
A lab-built angiotensin IV analog designed to supercharge brain synapse formation, and in rats it looked staggeringly potent. But it has never been proven in a human, and the drug company version built on the same target failed its big Alzheimer's trial in 2024.
Grade CCerebrolysin
A peptide mixture derived from pig brain that is actually approved and used for stroke and dementia in several countries, just not the US. It has a real stack of human trials, but the quality is mixed and the biggest stroke analyses came back neutral.
The monthly peptide evidence brief.
What the research and the FDA actually say, in one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.